Outcomes to be evaluated in the cohort study include:
- preterm birth and pregnancy-associated hypertensive disorders;
- other adverse pregnancy outcomes (stillbirth, premature labor without delivery, premature rupture of membranes (PROM), preterm PROM, cesarean delivery, prolonged maternal length of stay);
- maternal outcomes (thrombocytopenia, Guillain-Barre syndrome (GBS), other immune-mediated demyelinating conditions, polyneuropathies, atrial fibrillation);
- and neonatal/infant outcomes (small for gestational age [SGA], large for gestational age [LGA], low birth weight [LBW], admission to neonatal intensive care unit, mechanical ventilation in neonatal period, neonatal death).
The subset of priority outcomes to be evaluated in rapid cycle analysis include:
- preterm birth,
- pregnancy-associated hypertensive disorders,
- stillbirth,
- premature labor without premature delivery,
- PROM, PPROM, SGA, LGA, LBW, and GBS.